Author

Lucas Adda

Institution: Cooperative Trials Group for Neuro-Oncology

Observed institutions: The University of Sydney, Cooperative Trials Group for Neuro-Oncology, National Health and Medical Research Council

ORCID: 0000-0002-8562-364X

Observed ORCID: 0000-0002-8562-364X

OpenAlex ID: A5030130429

[ 18 F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial

2023 · Eng-Siew Koh, Hui K Gan, et al. · BMJ Open · 26

Impact of [18F]FET-PET on MRI-based radiotherapy target volumes in newly diagnosed Glioblastoma: Results from the FET-PET in Glioblastoma (FIG) study TROG 18.06

2026 · Eng-Siew Koh, Roslyn J Francis, et al. · Neuro-Oncology

TIP-16. Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS (LUMOS2) study

2025 · Subotheni Thavaneswaran, Eng-Siew Koh, et al. · Neuro-Oncology

A prospective, multi-centre trial of FET-PET in glioblastoma patients - the TROG 18.06 FIG Study: results of the Nuclear Medicine and Radiation Oncology credentialing program

2022 · Eng-Siew Koh, Alisha Moore, et al. · WFNOS 2022 Abstract Book

Nimg-49. a Prospective, Multi-centre Trial of Fet-pet in Glioblastoma Patients - the Trog 18.06 Fig Study: Key Aspects of Imaging and Radiation Oncology Credentialing

2021 · Eng-Siew Koh, Roslyn J Francis, et al. · Neuro-Oncology

Works count: 5

Citation count: 26

H-index: 1

I10-index: 1